The Pharmaceutical Journal
Vol 274 No 7343 p387
2 April 2005

This article
Reprint   Photocopy

PDF 65K, Acrobat Reader

Products

SPC changes
• Zerit
Discontinued products
• Humatrope 4-unit vials
Supply issues
• Haelan cream and ointment
Counter products
• Ovex Suspension

SPC changes

Zerit
The summaries of product characteristics for Zerit (stavudine; Bristol-Myers Squibb) capsules and powder for oral solution now state that in HIV-infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy, an inflammatory reaction to asymptomatic or residual opportunistic pathogens may arise and cause serious clinical conditions or aggravation of symptoms. Asymptomatic hyperlactataemia has been added as a common adverse event. See SPC.

Back to Top

Discontinued products

Humatrope 4-unit vials
Humatrope (somatropin; Eli Lilly) 4iu (1.33mg) vials will be discontinued from 1 May. The company says that it will look to replace stock or credit customers for any remaining product after August. All other Humatrope presentations remain available.

Back to Top

Supply issues

Haelan cream and ointment
Haelan cream and ointment (fludroxycortide;Typharm) are now back in stock.

Back to Top

Counter products

Ovex Suspension
Ovex Suspension (mebendazole 100mg/5ml; McNeil) will be available from mid April. Recommended retail price, 30ml (six doses) £6.99. Legal category: P.

Back to Top